J
Jay A. Johnson
Researcher at University of California, Los Angeles
Publications - 13
Citations - 2529
Jay A. Johnson is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Transplantation & Intravascular ultrasound. The author has an hindex of 10, co-authored 13 publications receiving 2461 citations. Previous affiliations of Jay A. Johnson include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Effect of pravastatin on outcomes after cardiac transplantation.
Jon A. Kobashigawa,S. Katznelson,Hillel Laks,Jay A. Johnson,Lawrence A. Yeatman,X M Wang,D Chia,Paul I. Terasaki,A. Sabad,G. A. Cogert +9 more
TL;DR: After cardiac transplantation, pravastatin had beneficial effects on cholesterol levels, the incidence of rejection causing hemodynamic compromise, one-year survival, andThe incidence of coronary vasculopathy.
Journal ArticleDOI
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
Jon A. Kobashigawa,Leslie W. Miller,Dale G. Renlund,Robert M. Mentzer,Edwin L. Alderman,Robert C. Bourge,Maria Rosa Costanzo,Howard J. Eisen,Georges Dureau,R. Ratkovec,Manfred Hummel,David Ipe,Jay A. Johnson,Anne Keogh,Richard D. Mamelok,Donna Mancini,Frank W. Smart,Hannah A. Valantine +17 more
TL;DR: Substitution of MMF for azathioprine may reduce mortality and rejection in the first year after cardiac transplantation.
Journal ArticleDOI
Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients
Howard J. Eisen,Jon A. Kobashigawa,Anne Keogh,Robert C. Bourge,Dale G. Renlund,Robert M. Mentzer,Edwin L. Alderman,Hannah A. Valantine,Georges Dureau,Donna Mancini,Richard D. Mamelok,Robert D. Gordon,Whedy Wang,Mandeep R. Mehra,Maria Rosa Constanzo,Manfred Hummel,Jay A. Johnson +16 more
TL;DR: MMF reduces mortality and graft loss up to 36 months after transplantation and in patients undergoing intravascular ultrasound, the change in mean maximal intimal thickness was less for the MMF group than for the AZA group.
Journal Article
Simultaneous Measurement of Myocardial Oxygen Consumption and Blood Flow Using (1-Carbon-11)Acetate
Karl T. Sun,Lawrence A. Yeatman,Denis B. Buxton,Kewei Chen,Jay A. Johnson,Sung-Cheng Huang,Klaus F. Kofoed,Susanne Weismueller,Johannes Czernin,Michael E. Phelps,Heinrich R. Schelbert +10 more
TL;DR: The proposed compartment model for [1-11C]acetate fits the measured kinetics well and, with proper calibration, allows estimation of absolute MVO2 rather than only an index of oxidative metabolism.
Journal ArticleDOI
Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: Correlation with high density lipoproteins☆
Dirk Hausmann,Jay A. Johnson,Krishnankutty Sudhir,William L. Mullen,Guy Friedrich,Peter J. Fitzgerald,Tony M. Chou,Thomas A. Ports,John P. Kane,Mary J. Malloy,Paul G. Yock +10 more
TL;DR: In patients with heterozygous familial hypercholesterolemia and familial combined hyperlipidemia, extensive coronary plaque is present despite minimal or no angiographic changes and levels of HDL cholesterol and total/HDL cholesterol ratio are far more powerful predictors of coronary plaque burden than are low density lipoprotein cholesterol levels in these patients with early, asymptomatic disease.